Search Results 831-840 of 19767 for Receptor
B., a Mayo Clinic cancer researcher, studies a type of cancer therapy called chimeric antigen receptor-T cell therapy, or CAR-T cell therapy. It was hailed ...
... receptor positive (ER+), human epidermal growth factor receptor 2 (HER2)-negative, unresectable, locally advanced and unresectable or metastatic breast cancer.
Oncologists currently recognize three basic types of breast tumors — estrogen-receptor (ER)-positive, HER2-positive, and triple negative. "But breast cancer ...
Multivariate analysis of HLA loci in conjunction with a thyrotropin receptor codon 52 polymorphism in conferring risk of Graves' disease. Thyroid. 1996 Aug; 6(4): ...
Progesterone receptor isoform-dependent cross-talk between prolactin and fatty acid synthase in breast cancer. Aging (Albany NY). 2020 Dec 10; 12(24):24671 ...
These new roles for activated receptors include stem cell expansion ... In addition to new druggable receptor targets, Dr. Scarisbrick's lab team ...
Diagnostic performance of somatostatin receptor positron emission tomography in preoperative evaluation of pancreatic neuroendocrine tumor lymph node metastases ...
Dopamine receptor blockers (neuroleptics); Metoclopramide; Reserpine. eCurrent treatment with anticoagulants (e.g., coumadin, heparin, oral thrombin inhibitors) ...
A Prospective Study to Evaluate the Role of Tumor Sequencing in Women Receiving Palbociclib for Advanced Hormone Receptor (HR)-Positive Breast Cancer ...
Clinical training · Hematopoietic stem cells · Mesenchymal stromal cells · Dendritic cells · Chimeric antigen receptor T cells.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.